ECSP982789A - EFFECTIVE COMBINATION FOR THE TREATMENT OF IMPOTENCE - Google Patents
EFFECTIVE COMBINATION FOR THE TREATMENT OF IMPOTENCEInfo
- Publication number
- ECSP982789A ECSP982789A ECSP982789A ECSP982789A EC SP982789 A ECSP982789 A EC SP982789A EC SP982789 A ECSP982789 A EC SP982789A EC SP982789 A ECSP982789 A EC SP982789A
- Authority
- EC
- Ecuador
- Prior art keywords
- treatment
- impotence
- effective combination
- compound selected
- combination
- Prior art date
Links
- 201000001881 impotence Diseases 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 abstract 2
- BNRNXUUZRGQAQC-UHFFFAOYSA-N sildenafil Chemical compound CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 abstract 2
- 208000010228 Erectile Dysfunction Diseases 0.000 abstract 1
- 239000000674 adrenergic antagonist Substances 0.000 abstract 1
- 102000004305 alpha Adrenergic Receptors Human genes 0.000 abstract 1
- 108090000861 alpha Adrenergic Receptors Proteins 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003623 enhancer Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229960003310 sildenafil Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Esta invención se refiere al tratamiento de la disfunción eréctil con una combinación de (1) un compuesto seleccionado entre antagonistas de los receptores alfa adrenérgicos y (2) un compuesto seleccionado entre los agentes que elevan los niveles de cGMP. Se prefiere como elevador de cGMP PDE al sildenafilo o una sal farmacéuticamente aceptable del mismo. También se incluyen composiciones y estuches que comprenden tales compuestos para el tratamiento de la impotencia.This invention relates to the treatment of erectile dysfunction with a combination of (1) a compound selected from among alpha adrenergic receptor antagonists and (2) a compound selected from among agents that raise cGMP levels. Sildenafil or a pharmaceutically acceptable salt thereof is preferred as a cGMP PDE enhancer. Also included are compositions and kits comprising such compounds for the treatment of impotence.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982789 ECSP982789A (en) | 1998-12-16 | 1998-12-16 | EFFECTIVE COMBINATION FOR THE TREATMENT OF IMPOTENCE |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982789 ECSP982789A (en) | 1998-12-16 | 1998-12-16 | EFFECTIVE COMBINATION FOR THE TREATMENT OF IMPOTENCE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP982789A true ECSP982789A (en) | 1999-04-21 |
Family
ID=42043708
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP982789 ECSP982789A (en) | 1998-12-16 | 1998-12-16 | EFFECTIVE COMBINATION FOR THE TREATMENT OF IMPOTENCE |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP982789A (en) |
-
1998
- 1998-12-16 EC ECSP982789 patent/ECSP982789A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4810381A1 (en) | EFFECTIVE COMBINATION FOR THE TREATMENT OF IMPOTENCE | |
| ES2175350T3 (en) | TRICICLIC COMPOUNDS THAT HAVE AFFINITY OF UNION TO MELATONINE RECEPTORS, THEIR PRODUCTION AND USE. | |
| ES2161231T3 (en) | HETEROCICLICAL COMPOUNDS AS AN ANTIGONIST OF BRADIQUININA. | |
| MX9501608A (en) | 1h-indole-3-glyoxylamide spla2 inhibitors. | |
| PA8546601A1 (en) | NEW INDOL DERIVATIVES WITH AFFINITY FOR THE 5-HT6 RECEIVER | |
| PA8547901A1 (en) | 4-PIPERACINYLINDOL DERIVATIVES WITH 5-HT6 RECEPTOR AFFINITY | |
| CO5160262A1 (en) | PHARMACEUTICAL FORMULATIONS OF CONTROLLED LIBERATION | |
| PA8586401A1 (en) | 4-PIPERAZINILBENCENOSULFONILINDOLES AND USE OF THE SAME | |
| ES2194567A1 (en) | 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors | |
| ES2159839T3 (en) | DERIVATIVES OF PROPANE, ITS PREPARATION AND ITS USE. | |
| PE20050130A1 (en) | ORGANIC COMPOUNDS | |
| PE20020366A1 (en) | PIPERAZINE DERIVATIVES AS LIGANDS OF THE 5HT2 RECEPTOR | |
| PE20060555A1 (en) | PIRROL-OXINDOL DERIVATIVES AS PROGESTERONE RECEPTOR MODULATORS | |
| CY1105146T1 (en) | THE USE OF ESTROGEN AGENTS / ANTAGONISTS IN THE TREATMENT OF SEXUAL DYSFUNCTION | |
| PE20060531A1 (en) | DERIVATIVES OF PYRIDAZIN-3- (2H) -ONE AS INHIBITORS OF PHOSPHODIESTERASE 4 | |
| ES2143049T3 (en) | SUBLINGUAL DOSAGE FORMS CONTAINING APOMORPHINE AND ITS USE FOR THE TREATMENT OF ERECTILE DYSFUNCTION. | |
| CR7235A (en) | BETA- AMINO TETRAHYDROIMIDAZOL (1,2-A) PIRAZIN AND TETRAHYDROTRIOAZOLO INHIBITORS (4,3-A) PIRAZINAS AS DEPETIDIL PEPTIDASE FOR THE TREATMENT OR PREVENTION OF DIABETES | |
| AR016399A1 (en) | PHARMACEUTICAL COMPOSITIONS, PHARMACEUTICAL COMPOSITIONS FOR USE WITH A SECOND COMPOSITION TO OBTAIN AN IMPROVEMENT IN THE THERAPEUTIC EFFECT, A KIT WHICH CONTAINS AND USE OF A COMPOUND TO PREPARE THE COMPOSITION | |
| ES2162933T3 (en) | USEFUL COMPOUNDS AS ANTIPROLIFERATIVE AND INHIBITING AGENTS OF THE RIBONUCLEOTIDO GLIBINAMIDE FORMULO TRANSFERASA (GARFT) ENZYME | |
| MX9306311A (en) | ANTAGONIST COMPOUNDS OF THE 5-HT4 RECEPTOR, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
| BR0004538A (en) | Effective combination for the treatment of impotence | |
| UY27232A1 (en) | NEW SUBSTITUTED CYAN DIHYDROPIRIMIDINE COMPOUNDS AND THEIR USE FOR TREATMENT OF MATTERS | |
| PE20040906A1 (en) | MORPHOLINE DERIVATIVES AS DOPAMINE AGONISTS | |
| ECSP982789A (en) | EFFECTIVE COMBINATION FOR THE TREATMENT OF IMPOTENCE | |
| ES2189956T3 (en) | DERIVATIVES OF QUINOLINA, PROCEDURES FOR ITS PREPARATION AND ITS USE AS MEDICATIONS. |